A drug approved for Alzheimer’s disease boosts social functioning in autistic children, according to a new study.
A randomized clinical trial involving 42 participants found that the drug, memantine, resulted in better social interactions and communication, researchers said in the study published on Oct. 1 by the Journal of the American Medical Association.
